|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Physics of Silicene Stripes显示文摘 | A. Kara C. Léandri M. E. Dávila P. Padova B. Ealet H. Oughaddou B. Aufray G. Lay | 2009 | Journal of Superconductivity and Novel Magnetism2009，，： | 3 |
| 2 | Germanene: a novel two-dimensional germanium allotrope akin to graphene and silicene显示文摘 | M E Dávila L Xian S Cahangirov A Rubio G Le Lay | 2014 | New Journal of Physics2014，，： | 3 |
| 3 | Physics and chemistry of silicene nano-ribbons显示文摘 | G. Le Lay B. Aufray C. Léandri H. Oughaddou J.-P. Biberian P. De Padova M.E. Dávila B. Ealet A. Kara | 2009 | Applied Surface Science2009，，： | 2 |
| 4 | Statistical evaluation of combined daily gauge observations and rainfall satellite estimates over continental South America显示文摘 | VILA D A GONCALVES L G TOLL D L | 2009 | Journal of Hydrometeorology2009，10，2： | 1 |
| 5 | Growth and field-emission properties of vertically aligned cobalt nanowire arrays显示文摘 | Vila L Vincent P Pra L D | 2004 | Nano Lett2004，4，3： | 1 |
| 6 | Liver failure after an uncovered TIPS procedure associated with hepatic infarction显示文摘Transjugular intrahepatic portosystemic shunt (TIPS) is a safe and effective procedure for the treatment of complications of liver cirrhosis, such as refractory ascites, hepatic hydrothorax and refractory variceal bleeding. The aim of this paper is to describe a rare case of liver failure after a TIPS procedure. A 38-year-old diabetic male with Child-Pugh C liver cirrhosis due to chronic hepatitis C infection who had developed refractory ascites was scheduled for a TIPS procedure. Within 24 h following TIPS placement, the patient developed distributive shock, jaundice, persistentgrade 3 hepatic encephalopathy, severe coagulopathy andacute renal failure. He was treated with lactulose enemas, broad-spectrum antibiotics and blood-derived products. Laboratory data revealed a 100-fold increase in aminotransferases and a non-enhanced computed tomography showed an irregular hypodense area in the right posterior segment of the liver. Despite being initially being in a stable condition, the patient developed progressive liver failure and died 2 mo later. Hepatic infarction is an uncommon phenomenon after a TIPS procedure; however, it can greatly complicate the course of a disease in a patient with an already compromised liver function. | Eric López-Méndez Daniel Zamora-Valdés Mariana Díaz-Zamudio Oscar F Fernández-Díaz Lourdes ávila | 2010 | World Journal of Hepatology2010，2，4： | 1 |
| 7 | Anterior pituitary devel opment and Pit-1/GHF-1 transcription factor 显示文摘 | Hoya D L Vila M Simenez V | 1998 | Cell Mol Life Sci1998，54，： | 1 |
| 8 | Controlled-release liquid suspensions based on ion-exchange particles entrapped within acrylic microcapsules显示文摘 | CUNA M VILA JATO J L TORRES D | 2000 | International Journal of Pharmaceuties2000，199，2： | 1 |
| 9 | Expression of the maize proteinase inhibitor (mpi) gene in rice plants enhances resistance against the striped stem borer (Chilo suppressalis): Effects on larval growth and insect gut proteinases 显示文摘 | VILA L QUILIS J MEYNARD D | 2005 | Plant Biotechnology Journal2005，3，： | 1 |
| 10 | The impact of Helicobacter pylori on atopic disorders in childhood 显示文摘 | Holster I L Vila A M Caudri D | 2012 | Helicobacter2012，17，3： | 1 |
| 11 | Radioactivity in bottled waters sold in Mexico显示文摘 | Dávila R JI López del RH García FM | 2002 | Appl Radiat Isotopes2002，56，6： | 1 |
| 12 | Recent trends in hydrogels based on starchgraft-acrylic acid:a review显示文摘 | Vilas D A Vidyagauri L | 2001 | Starch-Starke2001，53，1： | 1 |
| 13 | Role of 5-adenosine monophosphate-activated protein kinase in cell survival and death responses in neurons显示文摘 | WeisováP Dávila D Tuffy L P | 2011 | Antioxid Redox Signal2011，14，10： | 1 |
| 14 | Preparation and characterization of uniform, spherical particles of Y2O2S and Y2O2S:Eu 显示文摘 | VILA L D STUCCHI E B DAVOLOS M R | 1997 | Journal of Material Chemistry1997，7，10： | 1 |
| 15 | Association rules applied to credit card fraud detection显示文摘 | SaNCHEZ D VILA M A CERDA L | 2009 | Expert Systems with Applications2009，36，2： | 1 |
| 16 | Linezolidrelated immune-mediated severe thrombocytopenia显示文摘 | Pascoalinho D Vilas MJ Coelho L | | 0，，1： | 1 |
| 17 | 查看详情显示文摘 | López-Carrasquero F Giammanco G Díaz A Dávila J. Torres C. Laredo E | | 0，，1： | 1 |
| 18 | Forecast and tracking the evolution of cloud clusters (ForTraCC) using satellite显示文摘 | Vila D A Machado L A T Laurent H | 2008 | Weather and Forecasting2008，23，2： | 1 |
| 19 | What is the optimal level of vitamin D in non-dialysis chronic kidney disease population?显示文摘AIM To evaluate thresholds for serum 25(OH)D concentrations in relation to death, kidney progression and hospitalization in non-dialysis chronic kidney disease(CKD) population.METHODS Four hundred and seventy non-dialysis 3-5 stage CKD patients participating in OSERCE-2 study, a prospective, multicenter, cohort study, were prospectively evaluated and categorized into 3 groups according to 25(OH)D levels at enrollment(less than 20 ng/mL, between 20 and 29 ng/mL, and at or above 30 ng/mL), considering 25(OH)D between 20 and 29 ng/mL as reference group. Association between 25(OH)D levels and death(primary outcome), and time to first hospitalization and renal progression(secondary outcomes) over a 3-year followup, were assessed by Kaplan-Meier survival curves and Cox-proportional hazard models. To identify 25(OH)D levels at highest risk for outcomes, receiver operating characteristic(ROC) curves were performed.RESULTS Over 29 ± 12 mo of follow-up, 46(10%) patients dead, 156(33%) showed kidney progression, and 126(27%) were hospitalized. After multivariate adjustment, 25(OH)D < 20 ng/mL was an independent predictor of all-cause mortality(HR = 2.33; 95%CI: 1.10-4.91; P = 0.027) and kidney progression(HR = 2.46; 95%CI: 1.63-3.71; P < 0.001), whereas the group with 25(OH)D at or above 30 ng/mL did not have a different hazard for outcomes from the reference group. Hospitalization outcomes were predicted by 25(OH) levels(HR = 0.98; 95%CI: 0.96-1.00; P = 0.027) in the unadjusted Cox proportional hazards model, but not after multivariate adjusting. ROC curves identified 25(OH)D levels at highest risk for death, kidney progression, and hospitalization, at 17.4 ng/mL [area under the curve(AUC) = 0.60; 95%CI: 0.685-0.69; P = 0.027], 18.6 ng/mL(AUC = 0.65; 95%CI: 0.60-0.71; P < 0.001), and 19.0 ng/m L(AUC = 0.56; 95%CI: 0.50-0.62; P = 0.048), respectively.CONCLUSION25(OH)D < 20 ng/mL was an independent predictor of death and progression in patients with stage 3-5 CKD, with no additional benefits when patients reached the levels at or above 30 ng/m L suggested as optimal by CKD guidelines. | Pablo Molina JoséL Górriz Mariola D Molina Sandra Beltrán Belén Vizcaíno Verónica Escudero Julia Kanter Ana Iávila Jordi Bover Elvira Fernández Javier Nieto Secundino Cigarrán Enrique Gruss Gema Fernández-Juárez Alberto Martínez-Castelao Juan F Navarro-González Ramón Romero Luis M Pallardó | 2016 | World Journal of Nephrology2016，5，5： | 1 |
| 20 | Linezolid-related immuune-mediated severe thrombocytopenia显示文摘 | Pascoalinho D Vilas M J Coelho L | | 0，，01： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员